Skip to main content
Premium Trial:

Request an Annual Quote

Biotage s Aims to Begin Employee Stock Option Program

NEW YORK, March 23 (GenomeWeb News) - Biotage's board of directors may soon establish an employee stock option program after its April 27 meeting, the company said today in a statement.


If voting during the company's general meeting authorizes the board to make the changes, the total number of shares will not exceed 8.8 million, the firm said. Like other companies, Biotage issues new shares to help finance acquisitions or to strengthen its capital base and its equity holdings, the company added.


The board's plan for a stock option program will allow employees to be allocated no more than a combined total of 600,000 options until next year's general meeting. Management may be allocated as many as 80,000 options each, senior executives can receive a maximum of 30,000 options each, junior executives can each receive as many as 10,000 options, while other executives can receive a maximum of 3,600 each, the company said.


Other employees can receive a maximum of 400 options each.


The company will issue no more than 700,000 warrants, which if fully exercised will result in a market capitalization increase of 700,000 Swedish Kronor ($90,300), Biotage said. That amount corresponds to a dilution of less than one percent of the share capital and votes, the company added.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.